Evolus, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EOLS Nasdaq 2830 www.evolus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Evolus, Inc.

April 2026's Leading Growth Stocks With Insider Confidence - Apr 16th, 2026 11:36 am
Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference - Apr 15th, 2026 10:02 pm
Evolus to Report First Quarter Financial Results on May 4, 2026 - Apr 14th, 2026 6:30 am
How The Evolus (EOLS) Investment Story Is Shifting After Softer Guidance And Target Cuts - Apr 11th, 2026 7:08 am
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization - Apr 7th, 2026 1:35 pm
Telix Appoints David Gill as Non-Executive Director - Apr 1st, 2026 5:53 pm
Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference - Mar 31st, 2026 6:00 am
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 20th, 2026 2:05 pm
Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference - Mar 15th, 2026 5:32 pm
How The Narrative On Evolus (EOLS) Is Resetting After Cautious 2025 And 2026 Guidance - Mar 12th, 2026 5:13 pm
Why Evolus Stock Soared Today - Mar 4th, 2026 9:05 pm
Evolus, Inc. Q4 2025 Earnings Call Summary - Mar 4th, 2026 6:30 am
Evolus Inc (EOLS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Mar 3rd, 2026 10:01 pm
Evolus Q4 Earnings Call Highlights - Mar 3rd, 2026 5:02 pm
Evolus (EOLS) Q4 2025 Earnings Call Transcript - Mar 3rd, 2026 4:11 pm
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates - Mar 3rd, 2026 4:05 pm
Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 - Mar 3rd, 2026 2:05 pm
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates - Feb 25th, 2026 5:25 pm
Evolus to Participate in The Leerink Partners Global Healthcare Conference - Feb 25th, 2026 6:00 am
Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Feb 24th, 2026 8:00 am